Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children
Prathima Nandivada, Gillian L Fell, Kathleen M Gura, Mark Puder, Prathima Nandivada, Gillian L Fell, Kathleen M Gura, Mark Puder
Abstract
Long-term parenteral nutrition (PN) carries the risk of progressive liver disease in infants with intestinal failure. Although PN-associated liver disease (PNALD) is multifactorial in etiology, components of soybean oil lipid emulsions have been implicated in the disease's pathogenesis. Historically, infants with PNALD who were unable to wean from PN to full enteral feeding developed cirrhosis and end-stage liver disease, which require liver transplantation to survive. Over the past 2 decades, novel strategies for the management of parenteral lipids have improved morbidity and mortality from PNALD in infants with intestinal failure. Current strategies for the treatment of PNALD include restricting the dose of parenteral soybean oil lipid emulsion and/or replacing the soybean oil with a parenteral fish-oil lipid emulsion or emulsions of mixed-lipid sources. The purpose of this report is to review published data that evaluate these strategies in parenteral lipid management for the treatment and prevention of PNALD.
Keywords: PNALD; fish oil; intestinal failure; lipid emulsions; liver disease; parenteral lipids; soybean oil.
© 2016 American Society for Nutrition.
Source: PubMed